Sales for Krka and Lek, the two largest pharmaceutical companies in Slovenia, rose by 10.2% and 51.9% in 2003 to reach Tol97 billion and Tol145 billion, respectively
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.447, 2004-01, pp. : 15-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract